Matt Hewitt
Stock Analyst at Craig-Hallum
(3.81)
# 2,003
Out of 4,649 analysts
800
Total ratings
46%
Success rate
4.3%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PARK Park Dental Partners | Reiterated: Buy | $30 | $22.97 | +30.61% | 7 | Aug 14, 2026 | |
| DYAI Dyadic International | Maintained: Buy | $4 | $0.7751 | +416.06% | 14 | Aug 13, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $370 | $294.60 | +25.60% | 71 | Aug 7, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $20 | $15.25 | +31.15% | 9 | Aug 7, 2026 | |
| OABI OmniAb | Reiterated: Buy | $7 | $3.38 | +107.10% | 29 | Aug 7, 2026 | |
| CERT Certara | Maintained: Hold | n/a | $8.00 | - | 18 | Aug 4, 2026 | |
| CDXS Codexis | Maintained: Buy | n/a | $1.56 | - | 52 | Jul 24, 2026 | |
| BLFS BioLife Solutions | Downgraded: Hold | $31 | $35.07 | -11.61% | 35 | Jul 22, 2026 | |
| BHST BioHarvest Sciences | Maintained: Buy | n/a | $2.07 | - | 19 | Jul 15, 2026 | |
| SLP Simulations Plus | Rated: Hold | n/a | $18.35 | - | 53 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.59 | - | 52 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.72 | - | 39 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.32 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $166.83 | - | 57 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.29 | - | 21 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.30 | - | 48 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.60 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.27 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.03 | +98.02% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $5.70 | -12.28% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.94 | +38.22% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.5931 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $101.41 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.07 | +136.92% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.10 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.60 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.93 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.94 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.30 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.22 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.25 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $2.86 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.05 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.81 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $15.85 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $72.40 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.27 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $90.80 | n/a | 1 | Nov 8, 2017 |
Park Dental Partners
Aug 14, 2026
Reiterated: Buy
Price Target: $30
Current: $22.97
Upside: +30.61%
Dyadic International
Aug 13, 2026
Maintained: Buy
Price Target: $4
Current: $0.7751
Upside: +416.06%
Ligand Pharmaceuticals
Aug 7, 2026
Reiterated: Buy
Price Target: $370
Current: $294.60
Upside: +25.60%
Cryoport
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $15.25
Upside: +31.15%
OmniAb
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $3.38
Upside: +107.10%
Certara
Aug 4, 2026
Maintained: Hold
Price Target: n/a
Current: $8.00
Upside: -
Codexis
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $1.56
Upside: -
BioLife Solutions
Jul 22, 2026
Downgraded: Hold
Price Target: $31
Current: $35.07
Upside: -11.61%
BioHarvest Sciences
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $2.07
Upside: -
Simulations Plus
Jul 8, 2026
Rated: Hold
Price Target: n/a
Current: $18.35
Upside: -
Jul 8, 2026
Maintained: Buy
Price Target: n/a
Current: $17.59
Upside: -
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.72
Upside: -
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.32
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $166.83
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $7.29
Upside: -
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $37.30
Upside: -
Jun 2, 2026
Maintained: Hold
Price Target: n/a
Current: $4.60
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $12.27
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $3.03
Upside: +98.02%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $5.70
Upside: -12.28%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $28.94
Upside: +38.22%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $0.5931
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $101.41
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $5.07
Upside: +136.92%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $3.10
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $4.60
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $29.93
Upside: n/a
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $15.94
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $42.30
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.22
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $2.25
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $2.86
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $11.05
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $6.81
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $15.85
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $72.40
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $4.27
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $90.80
Upside: n/a